The Impact of Hypoglycemic Therapy on the Prognosis for Acute Coronary Syndrome in Patients with Type 2 Diabetes

The article discusses particular circumstances of acute coronary syndrome (ACS) in patients with type 2 diabetes (T2D). In addition, the available literature data and clinical guidelines reflecting the role of hypoglycemic therapy as a cardioprotection factor in ACS are analyzed. The article conside...

Full description

Saved in:
Bibliographic Details
Published in:Journal of personalized medicine 2022-05, Vol.12 (5), p.845
Main Authors: Nikolaev, K Yu, Shevela, A I, Mustafina, S V, Rymar, O D, Ovsyannikova, A K, Zelenskaya, E M, Kovaleva, A Y, Lifshits, G I
Format: Article
Language:English
Subjects:
Acute coronary syndromes
Atherosclerosis
Cardiac arrhythmia
Cardiomyocytes
Cardiovascular disease
Cardiovascular system
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetic neuropathy
Fatty acids
Glucose
Heart attacks
Hyperglycemia
Insulin resistance
Ischemia
Metabolism
Molecular modelling
Mortality
Pain
Patients
Potassium
Precision medicine
Prescription drugs
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The article discusses particular circumstances of acute coronary syndrome (ACS) in patients with type 2 diabetes (T2D). In addition, the available literature data and clinical guidelines reflecting the role of hypoglycemic therapy as a cardioprotection factor in ACS are analyzed. The article considers possible protective molecular mechanisms of various groups of drugs in ischemic cardiomyocytes.
ISSN:2075-4426
2075-4426
DOI:10.3390/jpm12050845